相似文献/References:
[1]林文毅,李荣建,赖娜,等.15653例宫颈液基薄层细胞学检查回顾性分析[J].中国计划生育和妇产科,2010,(03):0.
[2]石一复,李娟清.人乳头状瘤病毒及其预防性疫苗的现况[J].中国计划生育和妇产科,2011,(02):0.
[3]姜志欣,蔡瑞芬,林宁,等.人群大样本子宫颈癌筛查中宫颈涂片的质量控制[J].中国计划生育和妇产科,2012,(01):0.
JIANG Zhi-xin,CAI Rui-fen,LIN Ning,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(01):0.
[4]罗新,范瑾.hTERC基因检测技术在宫颈病变筛查中的地位[J].中国计划生育和妇产科,2013,(03):0.
LUO Xin,FAN Jin.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(01):0.
[5]姜志欣,吴玉璘.女性人乳头瘤病毒感染及相关肿瘤[J].中国计划生育和妇产科,2014,(07):0.
[6]魏秀莉.大麻素受体2与子宫颈癌组织内浸润T细胞亚群的关系[J].中国计划生育和妇产科,2017,(9):70.
WEI Xiu-li.The relationship between cannabinoid receptor 2 and infiltrating T-cell subsets in cervical cancer tissue[J].Chinese Journal of Family Planning & Gynecotokology,2017,(01):70.
[7]赵辉,吴玉梅*.同步放化疗对卵巢移位术后的早期宫颈癌患者
性生活质量影响[J].中国计划生育和妇产科,2017,(12):49.
ZHAO Hui,WU Yu-mei*.Effect of concurrent radiochemotherapy on quality of sexual life of early-stage cervical cancer patients after ovarian transposition[J].Chinese Journal of Family Planning & Gynecotokology,2017,(01):49.